Cadrenal Therapeutics, Inc Common Stock (CVKD) has had the highest return between 2023 and 2024 by a US stock in the Nasdaq Composite (IXIC), returning 999,233.3%.

ASSET	YEARS	% RETURN
Cadrenal Therapeutics, Inc Common Stock (CVKD)	2023-2024	999,233.33%
Tectonic Therapeutic (TECX)	2023-2024	907,447.17%
MGO Global Inc Common Stock (MGOL)	2023-2024	469,900%
Asset Entities Inc Class B Common Stock (ASST)	2023-2024	212,800%
MDxHealth SA ADR (MDXH)	2023-2024	187,900%
Agape ATP Corporation Common Stock (ATPC)	2023-2024	9,607.33%
Iteris (ITI)	2023-2024	8,716.35%
Dianthus Therapeutics (DNTH)	2023-2024	5,616.48%
iCoreConnect Inc Common stock (ICCT)	2023-2024	3,853.49%
Applovin (APP)	2023-2024	2,983.35%
MicroStrategy (MSTR)	2023-2024	2,796.14%
Soleno Therapeutics (SLNO)	2023-2024	2,664.59%
Root (ROOT)	2023-2024	2,393.84%
Sezzle Inc Common Stock (SEZL)	2023-2024	1,948.48%
Applied Opt (AAOI)	2023-2024	1,858.25%
Longboard Pharmaceuticals (LBPH)	2023-2024	1,661.41%
LENZ Therapeutics (LENZ)	2023-2024	1,453.41%
Innodata (INOD)	2023-2024	1,353.57%
Applied Therapeutics (APLT)	2023-2024	1,176.53%
American Coastal Insurance (ACIC)	2023-2024	1,134.86%
Cipher Mining (CIFR)	2023-2024	1,073.01%
Kingstone Companies (KINS)	2023-2024	1,047.73%
Terawulf (WULF)	2023-2024	1,011.94%
Corvus Pharmaceuticals (CRVS)	2023-2024	985.51%
Fortress Transp & Infra Inv (FTAI)	2023-2024	976.8%